Schonfeld Strategic Advisors LLC Uni Qure N.V. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 214,226 shares of QURE stock, worth $1.42 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
214,226
Previous 15,900
1247.33%
Holding current value
$1.42 Million
Previous $82,000
1069.51%
% of portfolio
0.01%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding QURE
# of Institutions
142Shares Held
33.7MCall Options Held
1.54MPut Options Held
389K-
Vestal Point Capital, LP New York, NY4.75MShares$31.6 Million1.59% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.65MShares$17.6 Million0.79% of portfolio
-
Black Rock Inc. New York, NY1.93MShares$12.8 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY1.9MShares$12.6 Million0.78% of portfolio
-
Schroder Investment Management Group London, X01.74MShares$11.6 Million0.01% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $311M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...